Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Ankylosing Spondylitis Market Expected to Grow Between 2025 And 2029?

The market for ankylosing spondylitis has seen significant growth in the recent past. The market is predicted to expand from a value of $5.9 billion in 2024 to $6.34 billion in 2025, correlating to a compound annual growth rate (CAGR) of 7.5%. Factors driving growth during the historic period include the discovery of hla-b27, the development of biologic treatments, advancements in pain management techniques, increased patient advocacy and awareness, and the use of NSAIDS and disease-modifying drugs.

The market for ankylosing spondylitis is predicted to experience substantial expansion in the forthcoming years. The market is anticipated to reach$8.68 billion by 2029 with a compound annual growth rate (CAGR) of 8.2%. The anticipated growth during this projection period can be traced back to factors such as a personalized approach to medicine, innovative development of biologics, early detection and intervention measures, managing lifestyle and diet, as well as the use of telemedicine and remote monitoring. Key trends for this period involve the availability of biosimilars, targeted pain treatments, focus on patient-reported outcomes (pros), societal support initiatives, and the exploration of regenerative medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11962&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnkylosing Spondylitis Market?

The growth of the ankylosing spondylitis market is predicted to be driven by the rising elderly population. This demographic refers to a surge in the percentage of aged individuals due to the alteration in population age distribution. This change has amplified the count and ratio of those who are more than 60 years old. Treatments and medications for ankylosing spondylitis aid in enhancing mobility and managing pain in elderly individuals affected by the condition. For example, the United Nations Department of Economic and Social Affairs (UN DESA), a department of the UN Secretariat based in the US, projected in January 2023 that the worldwide population of people age 65 and above will more than double, escalating from 761 million in 2021 to 1.6 billion by 2050. As a result, the rising number of elderly individuals is propelling the ankylosing spondylitis market’s expansion.

Which Segments in the Ankylosing Spondylitis Offer the Most Growth?

The ankylosing spondylitismarket covered in this report is segmented –

1) By Treatment Type: Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biological Therapies; Steroids; Physical Therapies; Surgery

2) By Molecule: Biologics; Biosimilar; Small Molecules

3) By Route Of Administration: Parenteral; Oral; Other Routes

4) By Application: Juveniles; Adults

5) By End User: Hospitals; Clinics; Research Laboratories; Other End Users

Subsegments:

1) By Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Over-The-Counter NSAIDs; Prescription NSAIDs

2) By Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Conventional DMARDs; Targeted DMARDs

3) By Biological Therapies: TNF Inhibitors; IL-17 Inhibitors

4) By Steroids: Oral Steroids; Injectable Steroids

5) By Physical Therapies: Physiotherapy; Exercise Programs

6) By Surgery: Joint Replacement Surgery; Spinal Surgery

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11962&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAnkylosing Spondylitis Market?# Market?

North America was the largest region in the ankylosing spondylitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ankylosing spondylitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Ankylosing Spondylitis Industry?

Progress in therapeutic solutions is a notable trend that is garnering increased attention in the ankylosing spondylitis market. Ankylosing spondylitis firms are introducing innovative therapeutic alternatives to retain their market standing. For instance, in April 2022, AbbVie Inc., a biopharmaceutical firm from the US, revealed that its RINVOQ received approval from the U.S. Food and Drug Administration (FDA) to treat adults suffering from active ankylosing spondylitis (AS). This presents a fresh oral therapeutic choice for patients who showed no response to TNF blockers, and it’s proven to significantly alleviate disease symptoms including back pain and impaired physical functions. Its swift effectiveness and safety evidence from clinical studies mark it as a crucial stride forward in managing this chronic inflammatory ailment, thereby broadening the array of therapeutic options accessible for patients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

What Are the Key Elements That Define the Ankylosing Spondylitis Market?

Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints (the joints connecting the lower spine to the pelvis). It involves inflammation of the joints and entheses and affects joints, leading to pain, stiffness, and progressive loss of mobility in the spine.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11962

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model